Long-Term Follow-Up of a Severe Eosinophilic Asthmatic Patient With Comorbid Nasal Polyposis Hospitalized for SARS-CoV-2 Infection While Receiving Benralizumab: A Case Report

We report a case of a patient affected by severe eosinophilic asthma with nasal polyps (SEA+NP) who developed coronavirus disease 2019 (COVID-19) six months after starting benralizumab as add-on therapy. Both SEA and NP were under control with no exacerbations at the time of severe acute respiratory...

Descripción completa

Detalles Bibliográficos
Autor principal: Ambrosino, Annamaria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Emergency Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752115/
https://www.ncbi.nlm.nih.gov/pubmed/35036198
http://dx.doi.org/10.7759/cureus.20364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8752115/
https://www.ncbi.nlm.nih.gov/pubmed/35036198
http://dx.doi.org/10.7759/cureus.20364

Ejemplares similares